Gene Expression Landscape of Chronic Myeloid Leukemia K562 Cells Overexpressing the Tumor Suppressor Gene PTPRG

This study concerns the analysis of the modulation of Chronic Myeloid Leukemia (CML) cell model K562 transcriptome following transfection with the tumor suppressor gene encoding for Protein Tyrosine Phosphatase Receptor Type G (PTPRG) and treatment with the tyrosine kinase inhibitor (TKI) Imatinib. Specifically, we aimed at identifying genes whose level of expression is altered by PTPRG modulation and Imatinib concentration. Statistical tests as differential expression analysis (DEA) supported by gene set enrichment analysis (GSEA) and modern methods of ontological term analysis are presented along with some results of current interest for forthcoming experimental research in the field of the transcriptomic landscape of CML. In particular, we present two methods that differ in the order of the analysis steps. After a gene selection based on fold-change value thresholding, we applied statistical tests to select differentially expressed genes. Therefore, we applied two different methods on the set of differentially expressed genes. With the first method (Method 1), we implemented GSEA, followed by the identification of transcription factors. With the second method (Method 2), we first selected the transcription factors from the set of differentially expressed genes and implemented GSEA on this set. Method 1 is a standard method commonly used in this type of analysis, while Method 2 is unconventional and is motivated by the intention to identify transcription factors more specifically involved in biological processes relevant to the CML condition. Both methods have been equipped in ontological knowledge mining and word cloud analysis, as elements of novelty in our analytical procedure. Data analysis identified RARG and CD36 as a potential PTPRG up-regulated genes, suggesting a possible induction of cell differentiation toward an erithromyeloid phenotype. The prediction was confirmed at the mRNA and protein level, further validating the approach and identifying a new molecular mechanism of tumor suppression governed by PTPRG in a CML context.

[1]  J. Gennari,et al.  The Ontology of Physics for Biology , 2023 .

[2]  C. Sorio,et al.  The Role of the Tumor Suppressor Gene Protein Tyrosine Phosphatase Gamma in Cancer , 2022, Frontiers in Cell and Developmental Biology.

[3]  Gheyath K Nasrallah,et al.  Description of PTPRG genetic variants identified in a cohort of Chronic Myeloid Leukemia patients and their ability to influence response to Tyrosine kinase Inhibitors. , 2021, Gene.

[4]  Guohui Xiao,et al.  Accessing scientific data through knowledge graphs with Ontop , 2021, Patterns.

[5]  C. Sorio,et al.  Current Views on the Interplay between Tyrosine Kinases and Phosphatases in Chronic Myeloid Leukemia , 2021, Cancers.

[6]  Muthanna Samara,et al.  Predictive value of tyrosine phosphatase receptor gamma for the response to treatment tyrosine kinase inhibitors in chronic myeloid leukemia patients , 2021, Scientific Reports.

[7]  L. Tomasello,et al.  Aberrant DNA methylation of PTPRG as one possible mechanism of its under‐expression in CML patients in the State of Qatar , 2020, Molecular genetics & genomic medicine.

[8]  L. Tomasello,et al.  Regulative Loop between β-catenin and Protein Tyrosine Receptor Type γ in Chronic Myeloid Leukemia , 2020, International journal of molecular sciences.

[9]  Chunhua Song,et al.  Cellular signaling and epigenetic regulation of gene expression in leukemia , 2019, Advances in biological regulation.

[10]  D. Sukhachev,et al.  Unique characteristics of leukocyte volume, conductivity and scatter in chronic myeloid leukemia , 2019, Biomedical journal.

[11]  Shiyong Li,et al.  Critical role of ASCT2-mediated amino acid metabolism in promoting leukaemia development and progression , 2019, Nature Metabolism.

[12]  K. Halfter,et al.  PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cells , 2018, Oncotarget.

[13]  L. Tomasello,et al.  A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients , 2017, Journal of Hematology & Oncology.

[14]  S. Dong,et al.  The Signaling Pathways Involved in Chondrocyte Differentiation and Hypertrophic Differentiation , 2016, Stem cells international.

[15]  P. Lecca,et al.  Accurate prediction of the age incidence of chronic myeloid leukemia with an improved two-mutation mathematical model. , 2016, Integrative biology : quantitative biosciences from nano to macro.

[16]  Wencui Sun,et al.  Early Development of Definitive Erythroblasts from Human Pluripotent Stem Cells Defined by Expression of Glycophorin A/CD235a, CD34, and CD36 , 2016, Stem cell reports.

[17]  Martin C. Müller,et al.  Response-related predictors of survival in CML , 2015, Annals of Hematology.

[18]  J. Melo,et al.  Natural course and biology of CML , 2015, Annals of Hematology.

[19]  L. Tomasello,et al.  Germline polymorphisms and survival of lung adenocarcinoma patients: A genome‐wide study in two European patient series , 2015, International journal of cancer.

[20]  J. Martens,et al.  The genome-wide molecular signature of transcription factors in leukemia. , 2014, Experimental hematology.

[21]  Carl R Walkley,et al.  Erythroid‐extrinsic regulation of normal erythropoiesis by retinoic acid receptors , 2014, British journal of haematology.

[22]  John H. Gennari,et al.  Ontology of physics for biology: representing physical dependencies as a basis for biological processes , 2013, Journal of Biomedical Semantics.

[23]  Paola Lecca,et al.  Parameter sensitivity analysis of stochastic models: Application to catalytic reaction networks , 2013, Comput. Biol. Chem..

[24]  E. Kohn,et al.  Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a src-dependent fashion , 2011, Angiogenesis.

[25]  Peter N. Robinson,et al.  Introduction to Bio-Ontologies , 2011 .

[26]  J. Dennis,et al.  Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia , 2010, Leukemia.

[27]  A. Burny,et al.  Acetylation of the human T-cell leukemia virus type 1 Tax oncoprotein by p300 promotes activation of the NF-kappaB pathway. , 2009, Virology.

[28]  S. Armstrong,et al.  Chromatin maps, histone modifications and leukemia , 2009, Leukemia.

[29]  Paola Lecca,et al.  A new probabilistic generative model of parameter inference in biochemical networks , 2009, SAC '09.

[30]  S. Gordon,et al.  The scavenger receptor CD36 plays a role in cytokine-induced macrophage fusion , 2009, Journal of Cell Science.

[31]  José L. V. Mejino,et al.  Bridging Biological Ontologies and Biosimulation: The Ontology of Physics for Biology , 2008, AMIA.

[32]  Andreas Hochhaus,et al.  Chronic myeloid leukaemia , 2007, The Lancet.

[33]  P. Chambon,et al.  A Microenvironment-Induced Myeloproliferative Syndrome Caused by Retinoic Acid Receptor γ Deficiency , 2007, Cell.

[34]  A. Scarpa,et al.  Expression of transmembrane protein tyrosine phosphatase gamma (PTPγ) in normal and neoplastic human tissues , 2007, Histopathology.

[35]  J. Huot,et al.  Endothelial cell migration during angiogenesis. , 2007, Circulation research.

[36]  Olivier Bodenreider,et al.  Bio-ontologies: current trends and future directions , 2006, Briefings Bioinform..

[37]  Paola Lecca,et al.  A time-dependent extension of gillespie algorithm for biochemical stochastic π-calculus , 2006, SAC.

[38]  J. Mesirov,et al.  From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005 .

[39]  Giovanni Parmigiani,et al.  Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers , 2004, Science.

[40]  J. Bard,et al.  Ontologies in biology: design, applications and future challenges , 2004, Nature Reviews Genetics.

[41]  E. Gunsilius,et al.  Hematopoietic stem cells in chronic myeloid leukemia. , 2003, Archives of medical research.

[42]  S. Kiryu-Seo,et al.  Damage-Induced Neuronal Endopeptidase (DINE/ECEL) Expression Is Regulated by Leukemia Inhibitory Factor and Deprivation of Nerve Growth Factor in Rat Sensory Ganglia after Nerve Injury , 2002, The Journal of Neuroscience.

[43]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[44]  L. Poels,et al.  Reduced expression of protein tyrosine phosphatase gamma in lung and ovarian tumors. , 1999, Cancer letters.

[45]  K. Huebner,et al.  Structure of the human receptor tyrosine phosphatase gamma gene (PTPRG) and relation to the familial RCC t(3;8) chromosome translocation. , 1996, Genomics.

[46]  P. D’Eustachio,et al.  Identification of a carbonic anhydrase-like domain in the extracellular region of RPTP gamma defines a new subfamily of receptor tyrosine phosphatases , 1993, Molecular and cellular biology.

[47]  Diego Calvanese,et al.  The Virtual Knowledge Graph System Ontop (Extended Abstract) , 2020, Description Logics.

[48]  Sorin Drăghici,et al.  Statistics and Data Analysis for Microarrays Using R and Bioconductor , 2016 .

[49]  G. Garcia-Manero,et al.  DNA methylation of membrane-bound tyrosine phosphatase genes in acute lymphoblastic leukaemia , 2014, Leukemia.

[50]  M. Wong,et al.  Lessons from development: A role for asymmetric stem cell division in cancer. , 2010, Stem cell research.

[51]  S. Hardy,et al.  Inside the human cancer tyrosine phosphatome , 2010, Nature Reviews Cancer.

[52]  T. Dillon,et al.  Ontologies for bioinformatics. , 2007, International journal of bioinformatics research and applications.

[53]  S. Sell,et al.  Leukemia , 2007, Stem Cell Reviews.

[54]  E. Koníková,et al.  P53 protein expression in human leukemia and lymphoma cells. , 2001, Neoplasma.

[55]  J. McCubrey,et al.  Serine/threonine phosphorylation in cytokine signal transduction , 2000, Leukemia.

[56]  C. Croce,et al.  Receptor protein tyrosine phosphatase gamma, Ptp gamma, regulates hematopoietic differentiation. , 1997, Blood.

[57]  Thomas Lengauer,et al.  Bioinformatics Original Paper Improved Scoring of Functional Groups from Gene Expression Data by Decorrelating Go Graph Structure , 2022 .